Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

A -- Therapies for Hematopoietic Syndrome, Bone Marrow Stromal Cell Loss and Vascular Injury Resulting From Acute Exposure to Ionizing Radiation

Solicitation Number: BAA-BARDA-08-08
Agency: Department of Health and Human Services
Office: Office of the Secretary
Location: Assistant Secretary for Preparedness and Response
  • Print

Opportunity History
:
BAA-BARDA-08-08
:
Award Notice
:
September 16, 2008
:
HHSO100200800063C
:
$3,361,352
:
Cellerant Therapeutics, Inc.
:
1561 Industrial Road
San Carlos, California 94070
United States
:
Department of Health and Human Services, Office of the Secretary, Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority 330 Independence Avenue, SW, Rm G640, Washington, DC, 20201, UNITED STATES
:
David K Beck,
Contracting Officer
Phone: 202-260-0453
Fax: 202-205-4520

All Files

Solicitation 1 Download compressed package in Zip format.
Mar 06, 2008
ARSBAA-06Mar08FinalCleanBV.pdf
Amendment 1 Download compressed package in Zip format.
Apr 30, 2008
BAA-BARDA 08-08 Amend #1 3-27-08 .pdf
PACKAGING AND DELIVERY OF THE PROPOSAL-Attachment B.pdf
Security Plan Attachment A.pdf

General Information

Notice Type:
Award Notice
Original Posted Date:
February 20, 2008
Posted Date:
September 17, 2008
Response Date:
-
Original Response Date:
April 17, 2008
Archiving Policy:
Automatic, on specified date
Original Archive Date:
May 2, 2008
Archive Date:
October 6, 2008
Original Set Aside:
N/A
Set Aside:
N/A
Classification Code:
A -- Research & Development
NAICS Code:
541 -- Professional, Scientific, and Technical Services/541712 -- Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)